1832 Asset Management’s ResMed RMD Stock Holding History

1832 Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.34M	Sell	37,173 -149	-0.4%	-$37.1K	0.01%	380
2025 Q4	$8.99M	Sell	37,322 -297	-0.8%	-$76K	0.01%	374
2025 Q3	$10.3M	Sell	37,619 -1,890	-5%	-$516K	0.01%	331
2025 Q2	$10.2M	Buy	39,509 +14,030	+55%	+$3.35M	0.01%	323
2025 Q1	$5.7M	Sell	25,479 -170	-0.7%	-$39.7K	0.01%	369
2024 Q4	$5.87M	Sell	25,649 -4,041	-14%	-$973K	0.01%	363
2024 Q3	$7.25M	Buy	29,690 +10	+0%	+$2.23K	0.01%	368
2024 Q2	$5.68M	Sell	29,680 -4,567	-13%	-$927K	﹤0.01%	373
2024 Q1	$6.78M	Buy	+34,247	New	+$6.28M	﹤0.01%	355
2021 Q4	–	Sell	-1,046	Closed	-$279K	–	847
2021 Q3	$279K	Buy	+1,046	New	+$286K	﹤0.01%	627

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

1832 Asset Management's RMD Position: Q1 2026 in Review

1832 Asset Management reduced its ResMed (RMD) stake by 0.4% in Q1 2026, selling an estimated $37.1K and leaving 37,173 shares worth $8.34M. The position accounts for 0.01% of the portfolio, ranked #380.

1832 Asset Management first reported a position in RMD in Q3 2021 and has held it in 10 quarters since. The position peaked at $10.3M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

1832 Asset Management held 37,173 shares of ResMed worth $8.34M as of Q1 2026.
1832 Asset Management sold 149 ResMed shares in Q1 2026, an estimated $37.1K.
ResMed made up 0.01% of 1832 Asset Management's portfolio in Q1 2026, its #380 holding.
1832 Asset Management first reported a position in ResMed in Q3 2021 and has held it in 10 quarters since.
1832 Asset Management's ResMed position peaked at $10.3M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.